Hyperuricemia: Clinical Trials

4 trials for Hyperuricemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 4
Phase 11Active not recruiting 1

Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
AR882 75 mg, XOI Low Dose, XOI High Dose - Gout, Gouty Arthritis
Phase 2Active not recruitingArthrosi Therapeutics152025-12-032026-05-15
PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function
SAP-001 - Gout, Hyperuricemia
Phase 1 / Phase 2Active not recruitingShanton Pharma Pte. Ltd.322024-04-242024-12-11
Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
SAP-001 - Gout
Phase 2Active not recruitingShanton Pharma Pte. Ltd.872022-12-122024-11-14
Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia
Febuxostat 80 MG Oral Tablet, vit E - Non Alcoholic Steatohepatitis, Hyperuricemia
Phase 2Active not recruitingTanta University702022-08-252025-01-23

Narrower conditions

Gout (3)  ·  Arthritis, Gouty (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Arthritis (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Crystal Arthropathies (3)  ·  Genetic Diseases, Inborn (3)  ·  Joint Diseases (3)  ·  Metabolic Diseases (3)  ·  Metabolism, Inborn Errors (3)  ·  Musculoskeletal Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Purine-Pyrimidine Metabolism, Inborn Errors (3)  ·  Rheumatic Diseases (3)  ·  Digestive System Diseases (1)  ·  Fatty Liver (1)

Interventions

Colchicine (1)  ·  Febuxostat (1)  ·  Tablets (1)  ·  Vitamin E (1)

Sponsors

Shanton Pharma Pte. Ltd. (2)  ·  Arthrosi Therapeutics (1)  ·  Tanta University (1)

Countries

United States (3)  ·  Egypt (1)  ·  Puerto Rico (1)

Top investigators

Carmen Arencibia (1)  ·  Robert Keenan, MD (1)

Results publications

PMID 40383220